Wyatt H. Home management of cystic fibrosis. British Journal of Home Healthcare 2009; 5.2: 4

British Journal of Home Healthcare

Reference list

Wyatt H. Home management of cystic fibrosis. British Journal of Home Healthcare 2009; 5.2: 4–6.

1. Fitzsimmons SC. The changing epidemiology of cystic fibrosis. J Pediatr 1993; 122: 1–9.

2. www.cftrust.org.uk/aboutcf/publications/cfregistryreports/UK_CF_Registry
_Annual_Data_Report_2007.pdf (last accessed 01/06/2009)

3. Dodge JA, Lewis PA, Stanton M, Wilsher J. Cystic fibrosis mortality and survival in the UK: 1947–2003. Eur Respir J 2007; 29: 522–526.

4. Kerem E, Conway S, Elborn S, Heijerman H; Consensus Committee. Standards of care for patients with cystic fibrosis: a European consensus. J Cyst Fibros 2005; 4: 7–26.

5. http://www.newbornbloodspot.screening.nhs.uk/cf (last accessed 01/06/2009)

6. Courtney JM, Bradley J, Mccaughan J et al. Predictors of mortality in adults with cystic fibrosis. Pediatr Pulmonol 2007; 42: 525–532.

7. Ojeniyi B, Frederiksen B, Hoiby N. Pseudomonas aeruginosa cross infection among patients with cystic fibrosis during a winter camp. Pediatr Pulmonol 2000; 29: 177–181.

8. Govan JR, Brown PH, Maddison J et al. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet 1993; 342: 15–9.

9. Saiman L, Siegel J, Cystic Fibrosis Foundation. Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission. Infect Control Hosp Epidemiol 2003; 24: S6–S52.

10. Balaguer A, González de Dios J. Home intravenous antibiotics for cystic fibrosis. Cochrane Database Syst Rev 2008; 3: CD001917.

11. Proesmans M, Heyns L, Moons P, Havermans T, De Boeck K. Real life evaluation of intravenous antibiotic treatment in a paediatric cystic fibrosis centre: outcome of home therapy is not inferior. Respir Med 2009; 103: 244–250.

12. Termoz A, Touzet S, Bourdy S et al. Effectiveness of home treatment for patients with cystic fibrosis: the intravenous administration of antibiotics to treat respiratory infections. Pediatr Pulmonol 2008; 43: 908–915.

13. Moran A, Hardin D, Rodman D et al. Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: a consensus conference report. Diabetes Res Clin Pract 1999; 45: 61–73.

14. Moyer K, Balistreri W. Hepatobiliary Disease in patients with cystic fibrosis. Curr Opin Gastroenterol 2009; 25: 272–278.

15. Yankaskas JR, Marshall BC, Sufian B, Simon RH, Rodman D. Cystic fibrosis adult care: consensus conference report. Chest 2004; 125(Suppl 1): 1S–39S.

16. Quittner AL, Barker DH, Snell C et aI. Prevalence and impact of depression in cystic fibrosis. Curr Opin Pulm Med 2008; 14: 582–588.

17. Campbell PW 3rd, Parker RA, Roberts BT, Krishnamani MR, Phillips JA 3rd. Association of poor clinical status and heavy exposure to tobacco smoke in patients with cystic fibrosis who are homozygous for the F508 deletion. J Pediatr 1992; 120: 261–264.

18. O'Connor GT, Quinton HB, Kneeland T et al. Median household income and mortality rate in cystic fibrosis. Pediatrics 2003; 111: e333–e339.

Published by Hayward Medical Communications